Approval · Notice of Compliance 36942 · 2026
ADVIL FLU: Notice of Compliance 36942
Issued February 13, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36942
- Date
- February 13, 2026
- Company
- Haleon Canada ULCMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL FLU | Not yet assigned | — |
Medicinal ingredients
- DIPHENHYDRAMINE HCL 25 MG per CAP
- IBUPROFEN 200 MG per CAP